期刊
TRENDS IN ENDOCRINOLOGY AND METABOLISM
卷 32, 期 4, 页码 212-223出版社
CELL PRESS
DOI: 10.1016/j.tem.2021.01.003
关键词
-
Endocrine disturbances play a key role in the pathophysiology of depression, affecting various neural sites and functions. Depression is associated with premature systemic diseases and a decreased response rate to current antidepressants, highlighting the need for new drug targets focusing on endocrine-mediated mechanisms.
Endocrine disturbances play predominant roles in recently discovered, clinically relevant abnormalities in depression. These affect multiple sites in the prefrontal cortex, amygdala, hippocampus, nucleus accumbens, and habenula. Deficits consist of changes in volume, neuroplasticity, neural connectivity, synapse composition, and neurogenesis. Depression is associated with endocrine-related, premature systemic disease, that results in a loss of approximately 7 years of life. CRH, glucocorticoids, somatostatin, gonadal steroids, and thyroid hormones all contribute to the deficits that largely define the pathophysiologic presentation of depression. The World Health Organization ranks depression as the second greatest cause of disability worldwide. The response rate to current antidepressants is below 60%. It is important that new knowledge about the endocrine-mediated pathophysiology of depression be communicated to provide targets for new agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据